Logo Image
|Articles|July 21, 2008

FDA retracts hold on alvimopan

However, partner in drug development deal may be backing out.

The U.S. Food & Drug Administration revoked a clinical hold on Entereg, according to Adolor Corp. The drug is under development for treatment of bowel dysfunction in individuals on opioid therapy. Despite this news, partner GlaxoSmithKline is considering backing out of the development arrangement.

Alvimopan (Entereg) received FDA approval in May for the treatment of post-operative ileus. The following month, FDA issued a hold on further studies of the drug pending submission and requested data analysis.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, .

Related Content

Latest CME

Expanding the Role of Long-Acting Injectables in Optimizing Schizophrenia Management
On-Demand Virtual Symposium

Expanding the Role of Long-Acting Injectables in Optimizing Schizophrenia Management

1.5 Credits / Psychiatry

View more
VMAT2 Inhibitors for Long-Term Success in Tardive Dyskinesia
On-Demand Virtual Symposium

VMAT2 Inhibitors for Long-Term Success in Tardive Dyskinesia

1.5 Credits / Neurology, Psychiatry

View more
Shifting Perspectives in Treatment-Resistant Depression: Novel Therapies and Patient-Centered Care
On-Demand Virtual Symposium

Shifting Perspectives in Treatment-Resistant Depression: Novel Therapies and Patient-Centered Care

1.5 Credits / Psychiatry

View more
Navigating Adverse Effects in HR+/HER2-Negative Metastatic Breast Cancer: Tailored Management Plans and Pharmacist Interventions for Improved Outcomes
On-Demand Webinar

Navigating Adverse Effects in HR+/HER2-Negative Metastatic Breast Cancer: Tailored Management Plans and Pharmacist Interventions for Improved Outcomes

1.0 Credits / Breast Cancer, Oncology, Women's Health

View more
Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer
On-Demand Webinar

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

0.75 Credits / Breast Cancer, Oncology, Women's Health

View more
Optimizing Therapy in HR+/HER2-Negative Metastatic Breast Cancer: Navigating Novel Treatments and Personalized Care
On-Demand Webinar

Optimizing Therapy in HR+/HER2-Negative Metastatic Breast Cancer: Navigating Novel Treatments and Personalized Care

1.0 Credits / Breast Cancer, Oncology, Women's Health

View more
Optimizing HER2-Directed Therapy in Metastatic Breast Cancer: From HER2-Positive to HER2-Ultralow
On-Demand Webinar

Optimizing HER2-Directed Therapy in Metastatic Breast Cancer: From HER2-Positive to HER2-Ultralow

1.5 Credit / Breast Cancer, Oncology, Women's Health

View more
Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches
On-Demand Webinar

Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches

1.0 Credits / Neurology

View more
Expert Insights on the Horizon of HER2-Directed Therapy
On-Demand Webinar

Expert Insights on the Horizon of HER2-Directed Therapy

0.5 Credit / Breast Cancer, Oncology, Women's Health

View more
Breaking Barriers in Asthma Care: Exploring the Role of Type 2 Inflammation and Biologic Therapies
On-Demand Virtual Symposium

Breaking Barriers in Asthma Care: Exploring the Role of Type 2 Inflammation and Biologic Therapies

1.5 Credit / Immunology, Pulmonology/Respiratory

View more
Type 2 Inflammation in Focus: Advancing Pediatric Atopic Dermatitis Care With Biologic Therapies
On-Demand Virtual Symposium

Type 2 Inflammation in Focus: Advancing Pediatric Atopic Dermatitis Care With Biologic Therapies

1.5 Credits / Dermatology, Immunology

View more
From Flares to Freedom: Navigating the Journey of Patients With Chronic Spontaneous Urticaria With Next-Generation Therapies
On-Demand Virtual Symposium

From Flares to Freedom: Navigating the Journey of Patients With Chronic Spontaneous Urticaria With Next-Generation Therapies

1.5 Credits / Immunology

View more
Chronic Obstructive Pulmonary Disease and Inflammation: Practical Approaches to Integrating Biologic Therapy
On-Demand Virtual Symposium

Chronic Obstructive Pulmonary Disease and Inflammation: Practical Approaches to Integrating Biologic Therapy

1.5 Credits / Immunology, Pulmonology/Respiratory

View more
Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases
On-Demand Virtual Symposium

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

1.0 Credit

View more
Innovations in Lymphoma Treatment and the Growing Impact of Bispecific Antibodies
Online Article

Innovations in Lymphoma Treatment and the Growing Impact of Bispecific Antibodies

2.0 Credits / Hematologic Cancer, Oncology

View more
Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care
On-Demand Panel Discussion

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

1.5 Credit / Hematology, Rare Diseases

View more
Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC
Online Article

Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC

2.0 Credits / Lung Cancer, Oncology, Pulmonology/Respiratory

View more
Payment for Pharmacist Services: 2025 Update
Online Article

Payment for Pharmacist Services: 2025 Update

1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law

View more
From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape
On-Demand Webinar

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

1.0 Credit / Immunology, Rare Diseases

View more
The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care
On-Demand Webinar

The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care

1.0 Credit / Oncology

View more
Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment
On-Demand Webinar

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

1.0 Credit / Nephrology

View more
Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes
On-Demand Webinar

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

1.75 Credit / Hematologic Cancer, Hematology, Oncology

View more
Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape
On-Demand Webinar

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

1.0 Credits / Dermatology, Immunology

View more
Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes
Online Article

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

2.0 Credits / Immunology, Rare Diseases, Hematology

View more
Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models
On-Demand Webinar

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

1.0 Credit / Immunology, Neurology, Rare Diseases

View more
Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists
On-Demand Webinar

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

1.25 Credits / Hematologic Cancer, Oncology

View more